All In MedTech

Device Trial Radar · NCT04112472

Clinical Trial ES 900 - 2019

Clinical Trial - ES 900 - 2019

Last checked: Nov 20, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

55

Actual

Start

Jul 11, 2019

Primary completion

Sep 1, 2019

Study completion Sep 1, 2019

Sponsor

Lead sponsor
Haag-Streit AGNot on our public-company list
Sponsor type
Industry
Collaborators
University Hospital, Basel, Switzerland
First posted
Oct 2, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this clinical trial is to assess the clinical performance of the investigational device. To that end, the Limits of Agreement with respect to comparator devices are analyzed. The Limits of Agreement allow estimating the expected measurement deviation per measurand, which is compared to the "maximum acceptable measurement error", as defined by the Risk Analysis of the investigational device, to assess the risk involved in measurements of the investigational device. Furthermore, the in-vivo repeatability will be quantified for each measurand, as well as the confidence intervals for mean deviation with respect to the current gold standard device. As a secondary objective of the study, raw measurement data will be collected to allow for improvement of existing algorithms, development of additional measurands and for retrospective analysis.

Conditions

  • Optical Biometry of the Human Eye
  • General Analysis of the Anterior Chamber of the Human Eye

Interventions

  • EYESTAR 900Device

    EYESTAR 900 is an optical biometry device used to create a geometrical representation of the eye by means of optical interferometry. The intervention are optical, non-contact examinations with the investigational device EYESTAR 900 and comparative device(s). Results of the examinations serve to compare the performance data of the investigational device with those of the comparative devices.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Keratometry Measurand: Kmean (Spherical refractive power of central cornea) in keratometric diopters [dpt]Time frame: Through study completion, approximately 7 months.

23 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hopital Basel

    Basel, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.